These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 7260903

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cellular basis for adriamycin-induced augmentation of cell-mediated cytotoxicity in culture.
    Ehrke MJ, Ryoyama K, Cohen SA.
    Cancer Res; 1984 Jun; 44(6):2497-504. PubMed ID: 6426781
    [Abstract] [Full Text] [Related]

  • 3. Increased primary cell-mediated immunity in culture subsequent to adriamycin or daunorubicin treatment of spleen donor mice.
    Orsini F, Pavelic Z, Mihich E.
    Cancer Res; 1977 Jun; 37(6):1719-26. PubMed ID: 66985
    [Abstract] [Full Text] [Related]

  • 4. Augmentation of the cell-mediated cytotoxic response induced in mixed cell culture by adriamycin.
    Arinaga S, Akiyoshi T, Tsuji H.
    Jpn J Cancer Res; 1985 May; 76(5):414-9. PubMed ID: 3159614
    [Abstract] [Full Text] [Related]

  • 5. Multiple tumoricidal effector mechanisms induced by adriamycin.
    Salazar D, Cohen SA.
    Cancer Res; 1984 Jun; 44(6):2561-6. PubMed ID: 6327018
    [Abstract] [Full Text] [Related]

  • 6. Effects of adriamycin on the activity of mouse natural killer cells.
    Santoni A, Riccardi C, Sorci V, Herberman RB.
    J Immunol; 1980 May; 124(5):2329-35. PubMed ID: 6444969
    [Abstract] [Full Text] [Related]

  • 7. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
    Liepins A, Nowicky JW.
    Drugs Exp Clin Res; 1996 May; 22(3-5):103-13. PubMed ID: 8899312
    [Abstract] [Full Text] [Related]

  • 8. Studies on T cell clonal expansion. I. Suppression of killer T cell production in vivo.
    Kamat R, Henney CS.
    J Immunol; 1975 Dec; 115(6):1592-8. PubMed ID: 810513
    [Abstract] [Full Text] [Related]

  • 9. Tumor cell-triggered macrophage-mediated suppression of the T-cell cytotoxic response to tumor-associated antigens. I. Characterization of the cell components for induction of suppression.
    Ting CC, Rodrigues D.
    J Natl Cancer Inst; 1982 Oct; 69(4):867-72. PubMed ID: 6214653
    [Abstract] [Full Text] [Related]

  • 10. Selective modulation by alpha-difluoromethylornithine of T-lymphocyte and antibody-mediated cytotoxic responses to mouse tumor allografts.
    Ehrke MJ, Porter CW, Eppolito C, Mihich E.
    Cancer Res; 1986 Jun; 46(6):2798-803. PubMed ID: 3084078
    [Abstract] [Full Text] [Related]

  • 11. The serologic response to Meth A sarcoma vaccines after cyclophosphamide treatment is additionally increased by various adjuvants.
    Livingston PO, Jones M, Deleo AB, Oettgen HF, Old LJ.
    J Immunol; 1985 Aug; 135(2):1505-9. PubMed ID: 4008930
    [Abstract] [Full Text] [Related]

  • 12. Macrophage requirement for in vitro generation of specific, secondary cell-mediated cytotoxicity against SV 40-induced tumor-associated antigens in mice.
    Glaser M.
    Eur J Immunol; 1980 May; 10(5):342-6. PubMed ID: 6250854
    [Abstract] [Full Text] [Related]

  • 13. Modulation of the cytotoxic response against allogeneic tumor cells in culture by adriamycin.
    Tomazic V, Ehrke MJ, Mihich E.
    Cancer Res; 1980 Aug; 40(8 Pt 1):2748-55. PubMed ID: 6248213
    [No Abstract] [Full Text] [Related]

  • 14. Acceleration of allogeneic antitumor immunity with immune RNA in vitro and T-cell suppression by L1210 tumor bearer spleen cells.
    Miura T, Maekawa T, Kurashige S, Mitsuhashi S.
    Cancer Res; 1981 Feb; 41(2):383-98. PubMed ID: 6160907
    [Abstract] [Full Text] [Related]

  • 15. Studies on T cell clonal expansion. II. The in vitro differentiation of pre-killer and memory T cells.
    Kamat R, Henney CS.
    J Immunol; 1976 May; 116(5):1490-5. PubMed ID: 178799
    [Abstract] [Full Text] [Related]

  • 16. Alterations in murine host defense functions by adriamycin or liposome-encapsulated adriamycin.
    Mace K, Mayhew E, Mihich E, Ehrke MJ.
    Cancer Res; 1988 Jan 01; 48(1):130-6. PubMed ID: 3257160
    [Abstract] [Full Text] [Related]

  • 17. Augmentation of specific cell-mediated immune responses to tumor cells in tumor-bearing rats pretreated wih the antileukemia drug busulfan.
    Mizushima Y, Sendo F, Miyake T, Kobayashi H.
    J Natl Cancer Inst; 1981 Apr 01; 66(4):659-65. PubMed ID: 6939913
    [Abstract] [Full Text] [Related]

  • 18. Correlation between adriamycin-induced augmentation of interleukin 2 production and of cell-mediated cytotoxicity in mice.
    Ehrke MJ, Maccubbin D, Ryoyama K, Cohen SA, Mihich E.
    Cancer Res; 1986 Jan 01; 46(1):54-60. PubMed ID: 3484381
    [Abstract] [Full Text] [Related]

  • 19. Immunologic control of a retrovirus-associated murine adenocarcinoma. VI. Augmentation of antibody-dependent killing following quantitative and qualitative changes in host peritoneal cells.
    Matthews TJ, Weinhold KJ, Langlois AJ, Bolognesi DP.
    J Natl Cancer Inst; 1985 Oct 01; 75(4):703-8. PubMed ID: 3862902
    [Abstract] [Full Text] [Related]

  • 20. Augmentation of the generation of cell-mediated cytotoxicity after a single dose of adriamycin in cancer patients.
    Arinaga S, Akiyoshi T, Tsuji H.
    Cancer Res; 1986 Aug 01; 46(8):4213-6. PubMed ID: 3488123
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.